Search research articles
Contact Us
Filters
Showing results (271-280 of 314) with videos related to
Page
of 32
Sort By:
International Journal of Molecular Medicine
|
July 2, 2019
Epigenetic regulation of COX‑2 expression by DNA hypomethylation via NF‑κB activation in ketamine‑induced ulcerative cystitis
Shu-Mien Chuang, Jian-He Lu, Kun-Ling Lin, et al.
International Journal of Molecular Sciences
|
September 10, 2021
Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration and Improves Overactive Bladder Induced by Ovarian Hormone Deficiency from Rat Animal Model to Human Clinical Trial
Kun-Ling Lin, Jian-He Lu, Kuang-Shun Chueh, et al.
Biology
|
July 2, 2021
Low Intensity Extracorporeal Shock Wave Therapy as a Potential Treatment for Overactive Bladder Syndrome
Jian-He Lu, Kuang-Shun Chueh, Shu-Mien Chuang, et al.
Scientific Reports
|
April 4, 2020
Therapeutic effects of Low intensity extracorporeal low energy shock wave therapy (LiESWT) on stress urinary incontinence
Cheng-Yu Long, Kun-Ling Lin, Yung-Chin Lee, et al.
International Journal of Molecular Sciences
|
May 13, 2023
Effects of Therapeutic Platelet-Rich Plasma on Overactive Bladder via Modulating Hyaluronan Synthesis in Ovariectomized Rat
Jian-He Lu, Kuang-Shun Chueh, Tai-Jui Juan, et al.
Biomed Research International
|
July 30, 2020
Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study
Yung-Chin Lee, Shu-Mien Chuang, Kun-Ling Lin, et al.
Signal Transduction and Targeted Therapy
|
May 14, 2026
HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial
Shao-Hua Li, Zhi-Jun Zuo, Liang-He Lu, et al.
BMC Cancer
|
July 1, 2020
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
Yi-Hong Ling, Jie-Wei Chen, Shi-Hong Wen, et al.
Toxics
|
June 25, 2025
The Impact of Boron Carbide Nanoparticle (B4C-NPs) Toxicity on <i>Caenorhabditis elegans</i> Models
Sen-Ting Huang, Erin P Bulaon, Kai-Jie Yang, et al.
Cancer Research
|
March 18, 2004
Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin
Véronique Trochon-Joseph, Dominique Martel-Renoir, Lluis M Mir, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 314) with videos related to
Sort By:
Page
of 32
International Journal of Molecular Medicine
|
July 2, 2019
Epigenetic regulation of COX‑2 expression by DNA hypomethylation via NF‑κB activation in ketamine‑induced ulcerative cystitis
Shu-Mien Chuang, Jian-He Lu, Kun-Ling Lin, et al.
International Journal of Molecular Sciences
|
September 10, 2021
Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration and Improves Overactive Bladder Induced by Ovarian Hormone Deficiency from Rat Animal Model to Human Clinical Trial
Kun-Ling Lin, Jian-He Lu, Kuang-Shun Chueh, et al.
Biology
|
July 2, 2021
Low Intensity Extracorporeal Shock Wave Therapy as a Potential Treatment for Overactive Bladder Syndrome
Jian-He Lu, Kuang-Shun Chueh, Shu-Mien Chuang, et al.
Scientific Reports
|
April 4, 2020
Therapeutic effects of Low intensity extracorporeal low energy shock wave therapy (LiESWT) on stress urinary incontinence
Cheng-Yu Long, Kun-Ling Lin, Yung-Chin Lee, et al.
International Journal of Molecular Sciences
|
May 13, 2023
Effects of Therapeutic Platelet-Rich Plasma on Overactive Bladder via Modulating Hyaluronan Synthesis in Ovariectomized Rat
Jian-He Lu, Kuang-Shun Chueh, Tai-Jui Juan, et al.
Biomed Research International
|
July 30, 2020
Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study
Yung-Chin Lee, Shu-Mien Chuang, Kun-Ling Lin, et al.
Signal Transduction and Targeted Therapy
|
May 14, 2026
HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial
Shao-Hua Li, Zhi-Jun Zuo, Liang-He Lu, et al.
BMC Cancer
|
July 1, 2020
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
Yi-Hong Ling, Jie-Wei Chen, Shi-Hong Wen, et al.
Toxics
|
June 25, 2025
The Impact of Boron Carbide Nanoparticle (B4C-NPs) Toxicity on <i>Caenorhabditis elegans</i> Models
Sen-Ting Huang, Erin P Bulaon, Kai-Jie Yang, et al.
Cancer Research
|
March 18, 2004
Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin
Véronique Trochon-Joseph, Dominique Martel-Renoir, Lluis M Mir, et al.
Page
of 32